FDA clears non-invasive blood pressure monitor:
This article was originally published in Clinica
Executive Summary
Medwave has received US FDA 510(k) clearance for its handheld, non-invasive blood pressure monitor. The Vasotrax device measures systolic and diastolic blood pressures and pulse rate from the radial artery on the wrist. Readings are displayed on the monitor in around 15 seconds. The St Paul, Minnesota company claims the device produces "significantly more accurate" results than the traditional blood pressure cuff and has been shown to have a mean correlation of around 0.9 compared with an indwelling arterial catheter.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.